Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 15696205

KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
PLoS Med
Publication date
2005 Jan
First author
Pao W

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    PLoS Med. 2005 Jan;2(1):e13. doi: 10.1371/journal.pmed.0020013.
    note
    Source null
    related pmid
    15696203
    relationship
    Comment in

Authors and identifiers

  1. name
    Pao W
    type
    Author
  2. name
    Wang TY
    type
    Author
  3. name
    Riely GJ
    type
    Author
  4. name
    Miller VA
    type
    Author
  5. name
    Pan Q
    type
    Author
  6. name
    Ladanyi M
    type
    Author
  7. name
    Zakowski MF
    type
    Author
  8. name
    Heelan RT
    type
    Author
  9. name
    Kris MG
    type
    Author
  10. name
    Varmus HE
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Pao W
    type
    Author
  2. name
    Wang TY
    type
    Author
  3. name
    Riely GJ
    type
    Author
  4. name
    Miller VA
    type
    Author
  5. name
    Pan Q
    type
    Author
  6. name
    Ladanyi M
    type
    Author
  7. name
    Zakowski MF
    type
    Author
  8. name
    Heelan RT
    type
    Author
  9. name
    Kris MG
    type
    Author
  10. name
    Varmus HE
    type
    Author
bibliography ids
  1. nci-bib-7b012a2719a65d94c58105ed
book metadata
content sha256
fb2e5d7b936210cfa5193ae9a24d8d10c30ce05bdb98b928925c5538edfd46c1
document type
citation
dois
  1. 10.1371/journal.pmed.0020017
electronic publication date
display
2005 Jan 25
precision
day
year
2005
evidence scope
bibliographic_metadata_only
id
pubmed:15696205
immutable id
pubmed:15696205@fb2e5d7b936210cfa5193ae9a24d8d10c30ce05bdb98b928925c5538edfd46c1
journal
abbreviation
PLoS Med
issn electronic
1549-1676
issn print
1549-1277
issue
1
name
PLoS medicine
nlm unique id
101231360
pages
e17
volume
2
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    PLoS Med. 2005 Jan;2(1):e13. doi: 10.1371/journal.pmed.0020013.
    note
    Source null
    related pmid
    15696203
    relationship
    Comment in
outcomes validated
false
pmid
15696205
provenance
batch id
c1587c4840dc976b65de
provider
NCBI PubMed ESummary
record sha256
e3fec4134a063e6df269f10d6ab279b3a923e7c021077298fe1a3999b3abbc15
response sha256
1dc03bdea4f6d08d05f92b6e458fb2ffa8a3c523f1f3e268fece6307fc70dead
retrieved at
2026-09-09T23:45:59.852120+00:00
publication date
display
2005 Jan
precision
month
year
2005
publication types
  1. Journal Article
  2. Research Support, N.I.H., Extramural
  3. Research Support, Non-U.S. Gov't
  4. Research Support, U.S. Gov't, P.H.S.
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/15696205/
title
KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib.

Preserved source evidence · Not medical advice